Quantum BioPharma Ltd. is a biopharmaceutical company focused on innovation and strategic investments in the healthcare sector. While it has a solid liquidity position with a current ratio of 1.41 and low debt levels (0.30), the company faces significant concerns with negative returns on equity (-61.5%) and assets (-37.6%), indicating operational challenges. The market cap of $29 million suggests potential undervaluation, but the negative financial metrics raise questions about sustainability and growth prospects. Overall, investors should weigh the company's liquidity strengths against its troubling profitability issues.
Loading financial metrics...
Company has $1.1M in cash but burned $2.2M last quarter. At this burn rate, only 0.5 quarters of runway remain without additional financing.
Company posted a loss of $-28.5M over the last year, representing Infinity% of revenue.
Operating cash flow has been negative for 3 consecutive quarters, burning $8.8M over the last year.
No significant opportunities identified
Based on current financial metrics
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Biotechnology companies of a similar size
Based on 2025-Q3 (September 30, 2025)